Healthcare Co., Ltd. (603313.SS)
CNY 7.61
(1.6%)
CNY 7.61
(1.6%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 916.62 Million | 565.39 Million | 67.92 Million | 582.52 Million | 129.79 Million | 175.03 Million |
| Net Income | 121.53 Million | 51.97 Million | -269.63 Million | 416.65 Million | 392.2 Million | 196.65 Million |
| Depreciation & Amortization | 505.67 Million | 444.06 Million | 360.06 Million | 132.97 Million | 76.92 Million | 52.21 Million |
| Deferred income taxes | -54.86 Million | -27.65 Million | -71.23 Million | -47.09 Million | 1.81 Million | -6.35 Million |
| Stock-based compensation | - | - | -6.36 Million | - | 12.07 Million | - |
| Change in working capital | -166.97 Million | -128.83 Million | -425.29 Million | -230.09 Million | -462.24 Million | -166.02 Million |
| Other non-cash items | 316.97 Million | 198.18 Million | 480.38 Million | 262.99 Million | 109.02 Million | 92.19 Million |
| Investing Cash Flow | -362.9 Million | -548.89 Million | -523.5 Million | -1.3 Billion | -939.25 Million | -504.09 Million |
| Investments in PPE | -414.52 Million | -631.06 Million | -539.44 Million | -915.43 Million | -784.11 Million | -418.62 Million |
| Acquisitions | 52.4 Million | 37.82 Million | 9.81 Million | -356.29 Million | -31.87 Million | 2.34 Million |
| Investment purchases | -11.64 Million | -13.91 Million | -20 Million | -85.77 Million | -79.25 Million | -30.25 Million |
| Sales/Maturities of investments | 2.34 Million | 6.09 Million | 4.04 Million | 531.78 Thousand | 923.39 Thousand | 2.47 Million |
| Other Investing Activities | -7.09 Million | 52.17 Million | 22.07 Million | 51.79 Million | -44.93 Million | -60.03 Million |
| Financing Cash Flow | -108.24 Million | -511.02 Million | 363.57 Million | 1.13 Billion | 540.21 Million | 767.93 Million |
| Debt repayment | -372.9 Million | -3.68 Billion | -2.23 Billion | -1.89 Billion | -668.08 Million | -511.26 Million |
| Dividends payments | -151.75 Million | -135.51 Million | -258.36 Million | -71.31 Million | -98.21 Million | -23.13 Million |
| Common Stock Repurchased | - | -6.94 Million | -6.44 Million | -673.44 Thousand | - | -639 Thousand |
| Common Stock Issuance | - | 6.94 Million | 6.44 Million | 673.44 Thousand | - | - |
| Other Financing Activities | 432.38 Million | 3.3 Billion | 2.85 Billion | 3.1 Billion | 1.34 Billion | 1.3 Billion |
| Accounts receivables | -358.16 Million | -61.15 Million | -289.22 Million | -293.59 Million | -467.48 Million | -179.18 Million |
| Accounts payables | 256.95 Million | -231.98 Million | 529.56 Million | 738.83 Million | 377.09 Million | 65.75 Million |
| Inventory | -10.88 Million | 191.96 Million | -594.39 Million | -628.24 Million | -373.67 Million | -46.24 Million |
| Other working capital | 202.08 Million | -27.65 Million | -71.23 Million | -47.09 Million | 1.81 Million | -119.78 Million |
| Cash at beginning of period | 452.8 Million | 777.12 Million | 1.06 Billion | 805.24 Million | 1.03 Billion | 602.66 Million |
| Cash at end of period | 990.03 Million | 452.8 Million | 777.12 Million | 1.06 Billion | 805.24 Million | 1.03 Billion |
| Capital Expenditure | -414.52 Million | -631.06 Million | -539.44 Million | -915.43 Million | -784.11 Million | -418.62 Million |
| Effect of forex changes on cash | 91.75 Million | 170.2 Million | -192.26 Million | -160.74 Million | 35.31 Million | -2.36 Million |
| Net cash flow / Change in cash | 537.23 Million | -324.32 Million | -284.27 Million | 256.14 Million | -233.93 Million | 436.51 Million |
| Free Cash Flow | 502.09 Million | -65.67 Million | -471.51 Million | -332.9 Million | -654.32 Million | -243.59 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -205.57 Million | 32.76 Million | 19.82 Million | 121.53 Million | -6.33 Million | 15.31 Million |
| Depreciation & Amortization | - | 198.63 Million | 198.63 Million | 505.67 Million | 179.06 Million | -237.81 Million |
| Deferred income taxes | - | - | - | -54.86 Million | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | - | - | -166.97 Million | -369.05 Million | 127.89 Million |
| Other non-cash items | 499.25 Million | 246.48 Million | 113.53 Million | 316.97 Million | 278.62 Million | 475.59 Million |
| Investing Cash Flow | -24.31 Million | -244.22 Million | -44.87 Million | -362.9 Million | -19.46 Million | -197.53 Million |
| Investments in PPE | -71.52 Million | -141.49 Million | -46.62 Million | -414.52 Million | -42.64 Million | -196.21 Million |
| Acquisitions | 50.22 Million | -3.09 Million | 1.4 Million | 52.4 Million | 17.22 Million | 35.54 Thousand |
| Investment purchases | 107.77 Million | -107.77 Million | - | -11.64 Million | -11.64 Million | -35.53 Thousand |
| Sales/Maturities of investments | -616.26 Thousand | 706.09 Thousand | 1.28 Million | 2.34 Million | -30.31 Million | 2.59 Million |
| Other Investing Activities | -110.17 Million | -105.5 Million | -1.64 Million | -7.09 Million | -232.96 Thousand | -3.91 Million |
| Financing Cash Flow | -307.39 Million | -31.93 Million | -214.43 Million | -108.24 Million | 496.44 Million | -236.94 Million |
| Debt repayment | -85.44 Million | -44.17 Million | -38.06 Million | -372.9 Million | -5.93 Million | -1.07 Billion |
| Dividends payments | - | -29.35 Million | -34.24 Million | -151.75 Million | -52.14 Million | -17.16 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -221.95 Million | -45.75 Million | -142.11 Million | 432.38 Million | 548.83 Million | 851.68 Million |
| Accounts receivables | - | - | - | -358.16 Million | -358.16 Million | 224.31 Million |
| Accounts payables | - | - | - | 256.95 Million | - | - |
| Inventory | - | - | - | -10.88 Million | -10.88 Million | -96.41 Million |
| Other working capital | - | - | - | - | - | - |
| Cash at beginning of period | 847.8 Million | 866.34 Million | 990.03 Million | 452.8 Million | 366.42 Million | 440.68 Million |
| Cash at end of period | 813.81 Million | 690.05 Million | 866.34 Million | 990.03 Million | 990.03 Million | 366.42 Million |
| Capital Expenditure | -71.52 Million | -141.49 Million | -46.62 Million | -414.52 Million | -42.64 Million | -196.21 Million |
| Effect of forex changes on cash | - | 19.96 Million | 3.53 Million | 91.75 Million | 37.72 Million | -20.76 Million |
| Net cash flow / Change in cash | -33.99 Million | -176.28 Million | -123.69 Million | 537.23 Million | 623.61 Million | -74.26 Million |
| Free Cash Flow | 222.15 Million | -60.88 Million | 86.73 Million | 502.09 Million | 50.58 Million | 184.77 Million |
MITFF
603565
POLP
003032
YURANUS
HAMR